{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:51:41Z","timestamp":1784958701072,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI166134"],"award-info":[{"award-number":["R21AI166134"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1038\/s41589-024-01559-8","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T11:02:54Z","timestamp":1709118174000},"page":"1144-1153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antiviral drug recognition and elevator-type transport motions of CNT3"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7406-2015","authenticated-orcid":false,"given":"Nicholas J.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-7309","authenticated-orcid":false,"given":"Yang","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin G.","family":"Fedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6679-2341","authenticated-orcid":false,"given":"Kedar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-1413","authenticated-orcid":false,"given":"Mario J.","family":"Borgnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5642-6041","authenticated-orcid":false,"given":"Wonpil","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-9921","authenticated-orcid":false,"given":"Seok-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"1559_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.antiviral.2018.11.016","volume":"162","author":"MK Yates","year":"2019","unstructured":"Yates, M. K. & Seley-Radtke, K. L. The evolution of antiviral nucleoside analogues: a review for chemists and non-chemists. Part II: complex modifications to the nucleoside scaffold. Antivir. Res. 162, 5\u201321 (2019).","journal-title":"Antivir. Res."},{"key":"1559_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","volume":"154","author":"KL Seley-Radtke","year":"2018","unstructured":"Seley-Radtke, K. L. & Yates, M. K. The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold. Antivir. Res. 154, 66\u201386 (2018).","journal-title":"Antivir. Res."},{"key":"1559_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coviro.2019.04.002","volume":"35","author":"AJ Pruijssers","year":"2019","unstructured":"Pruijssers, A. J. & Denison, M. R. Nucleoside analogues for the treatment of coronavirus infections. Curr. Opin. Virol. 35, 57\u201362 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"1559_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/rmv.483","volume":"16","author":"JD Graci","year":"2006","unstructured":"Graci, J. D. & Cameron, C. E. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 16, 37\u201348 (2006).","journal-title":"Rev. Med. Virol."},{"key":"1559_CR5","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19\u2014final report. N. Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1559_CR6","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","volume":"368","author":"E Lawitz","year":"2013","unstructured":"Lawitz, E. et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N. Engl. J. Med. 368, 1878\u20131887 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1559_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal, A. et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N. Engl. J. Med. 386, 509\u2013520 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1559_CR8","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","volume":"61","author":"Y Mehellou","year":"2018","unstructured":"Mehellou, Y., Rattan, H. S. & Balzarini, J. The ProTide prodrug technology: from the concept to the clinic. J. Med. Chem. 61, 2211\u20132226 (2018).","journal-title":"J. Med. Chem."},{"key":"1559_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren, T. K. et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381\u2013385 (2016).","journal-title":"Nature"},{"key":"1559_CR10","doi-asserted-by":"publisher","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","volume":"12","author":"TP Sheahan","year":"2020","unstructured":"Sheahan, T. P. et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med. 12, eabb5883 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1559_CR11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1021\/acsmedchemlett.0c00316","volume":"11","author":"VC Yan","year":"2020","unstructured":"Yan, V. C. & Muller, F. L. Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment. ACS Med. Chem. Lett. 11, 1361\u20131366 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"1559_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","volume":"585","author":"BN Williamson","year":"2020","unstructured":"Williamson, B. N. et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature 585, 273\u2013276 (2020).","journal-title":"Nature"},{"key":"1559_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"JJ Feld","year":"2005","unstructured":"Feld, J. J. & Hoofnagle, J. H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436, 967\u2013972 (2005).","journal-title":"Nature"},{"key":"1559_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","volume":"219","author":"BG Murphy","year":"2018","unstructured":"Murphy, B. G. et al. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet. Microbiol. 219, 226\u2013233 (2018).","journal-title":"Vet. Microbiol."},{"key":"1559_CR15","doi-asserted-by":"crossref","unstructured":"Agostini, M. L. et al. Small-molecule antiviral \u03b2-d-N4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J. Virol. 93, e01348-19 (2019).","DOI":"10.1128\/JVI.01348-19"},{"key":"1559_CR16","doi-asserted-by":"crossref","unstructured":"Toots, M. et al. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci. Transl. Med. 11, eaax5866 (2019).","DOI":"10.1126\/scitranslmed.aax5866"},{"key":"1559_CR17","doi-asserted-by":"crossref","unstructured":"Yoon, J. J. et al. Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses. Antimicrob. Agents Chemother. 62, e00766-18 (2018).","DOI":"10.1128\/AAC.00766-18"},{"key":"1559_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature22057","volume":"545","author":"M Hirschi","year":"2017","unstructured":"Hirschi, M., Johnson, Z. L. & Lee, S. Y. Visualizing multistep elevator-like transitions of a nucleoside transporter. Nature 545, 66\u201370 (2017).","journal-title":"Nature"},{"key":"1559_CR19","doi-asserted-by":"publisher","first-page":"e03604","DOI":"10.7554\/eLife.03604","volume":"3","author":"ZL Johnson","year":"2014","unstructured":"Johnson, Z. L. et al. Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters. eLife 3, e03604 (2014).","journal-title":"eLife"},{"key":"1559_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature10882","volume":"483","author":"ZL Johnson","year":"2012","unstructured":"Johnson, Z. L., Cheong, C. G. & Lee, S. Y. Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4\u2009\u00c5. Nature 483, 489\u2013493 (2012).","journal-title":"Nature"},{"key":"1559_CR21","doi-asserted-by":"publisher","first-page":"e3000790","DOI":"10.1371\/journal.pbio.3000790","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Cryo-EM structure of the human concentrative nucleoside transporter CNT3. PLoS Biol. 18, e3000790 (2020).","journal-title":"PLoS Biol."},{"key":"1559_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","volume":"34","author":"JD Young","year":"2013","unstructured":"Young, J. D., Yao, S. Y., Baldwin, J. M., Cass, C. E. & Baldwin, S. A. The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol. Asp. Med. 34, 529\u2013547 (2013).","journal-title":"Mol. Asp. Med."},{"key":"1559_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41594-019-0245-7","volume":"26","author":"NJ Wright","year":"2019","unstructured":"Wright, N. J. & Lee, S. Y. Structures of human ENT1 in complex with adenosine reuptake inhibitors. Nat. Struct. Mol. Biol. 26, 599\u2013606 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1559_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37411-1","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1. Nat. Commun. 14, 1727 (2023).","journal-title":"Nat. Commun."},{"key":"1559_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1478-3231.2011.02727.x","volume":"32","author":"A Tsubota","year":"2012","unstructured":"Tsubota, A. et al. Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients. Liver Int. 32, 826\u2013836 (2012).","journal-title":"Liver Int"},{"key":"1559_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/FPC.0b013e32834412e7","volume":"21","author":"A Doehring","year":"2011","unstructured":"Doehring, A. et al. Role of nucleoside transporters SLC28A2\/3 and SLC29A1\/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. Pharmacogenet. Genomics 21, 289\u2013296 (2011).","journal-title":"Pharmacogenet. Genomics"},{"key":"1559_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jhep.2012.11.027","volume":"58","author":"M Rau","year":"2013","unstructured":"Rau, M. et al. Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. J. Hepatol. 58, 669\u2013675 (2013).","journal-title":"J. Hepatol."},{"key":"1559_CR28","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1128\/AAC.05762-11","volume":"56","author":"M Iikura","year":"2012","unstructured":"Iikura, M. et al. ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system. Antimicrob. Agents Chemother. 56, 1407\u20131413 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1559_CR29","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1086\/656334","volume":"202","author":"J Morello","year":"2010","unstructured":"Morello, J. et al. Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon\u2013ribavirin therapy in patients with chronic hepatitis C virus infection. J. Infect. Dis. 202, 1185\u20131191 (2010).","journal-title":"J. Infect. Dis."},{"key":"1559_CR30","doi-asserted-by":"crossref","unstructured":"Rasmussen, H. B. et al. Cellular uptake and intracellular phosphorylation of GS-441524: implications for its effectiveness against COVID-19. Viruses 13, 1369 (2021).","DOI":"10.3390\/v13071369"},{"key":"1559_CR31","doi-asserted-by":"publisher","first-page":"918083","DOI":"10.3389\/fphar.2022.918083","volume":"13","author":"AQ Wang","year":"2022","unstructured":"Wang, A. Q. et al. Preclinical pharmacokinetics and in vitro properties of GS-441524, a potential oral drug candidate for COVID-19 treatment. Front. Pharmacol. 13, 918083 (2022).","journal-title":"Front. Pharmacol."},{"key":"1559_CR32","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1021\/acs.chemrev.0c00644","volume":"121","author":"NJ Wright","year":"2021","unstructured":"Wright, N. J. & Lee, S. Y. Toward a molecular basis of cellular nucleoside transport in humans. Chem. Rev. 121, 5336\u20135358 (2021).","journal-title":"Chem. Rev."},{"key":"1559_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/09687860600942534","volume":"24","author":"KM Smith","year":"2007","unstructured":"Smith, K. M. et al. Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3. Mol. Membr. Biol. 24, 53\u201364 (2007).","journal-title":"Mol. Membr. Biol."},{"key":"1559_CR34","doi-asserted-by":"publisher","first-page":"27981","DOI":"10.1074\/jbc.M100518200","volume":"276","author":"SR Hamilton","year":"2001","unstructured":"Hamilton, S. R. et al. Subcellular distribution and membrane topology of the mammalian concentrative Na+\u2013nucleoside cotransporter rCNT1. J. Biol. Chem. 276, 27981\u201327988 (2001).","journal-title":"J. Biol. Chem."},{"key":"1559_CR35","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1096\/fj.15-272773","volume":"30","author":"P Fernandez-Calotti","year":"2016","unstructured":"Fernandez-Calotti, P., Casulleras, O., Antolin, M., Guarner, F. & Pastor-Anglada, M. Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its function. FASEB J. 30, 544\u2013554 (2016).","journal-title":"FASEB J."},{"key":"1559_CR36","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/cbic.201100567","volume":"12","author":"VL Damaraju","year":"2011","unstructured":"Damaraju, V. L. et al. Influence of sugar ring conformation on the transportability of nucleosides by human nucleoside transporters. ChemBioChem 12, 2774\u20132778 (2011).","journal-title":"ChemBioChem"},{"key":"1559_CR37","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1021\/acs.molpharmaceut.7b00085","volume":"14","author":"C Arimany-Nardi","year":"2017","unstructured":"Arimany-Nardi, C. et al. Identification and characterization of a secondary sodium-binding site and the main selectivity determinants in the human concentrative nucleoside transporter 3. Mol. Pharm. 14, 1980\u20131987 (2017).","journal-title":"Mol. Pharm."},{"key":"1559_CR38","doi-asserted-by":"publisher","first-page":"e4525","DOI":"10.1002\/pro.4525","volume":"32","author":"M Gucwa","year":"2023","unstructured":"Gucwa, M. et al. CMM\u2014an enhanced platform for interactive validation of metal binding sites. Protein Sci. 32, e4525 (2023).","journal-title":"Protein Sci."},{"key":"1559_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mol.110.063552","volume":"78","author":"E Errasti-Murugarren","year":"2010","unstructured":"Errasti-Murugarren, E., Molina-Arcas, M., Casado, F. J. & Pastor-Anglada, M. The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs. Mol. Pharmacol. 78, 157\u2013165 (2010).","journal-title":"Mol. Pharmacol."},{"key":"1559_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1124\/mol.105.012187","volume":"68","author":"J Zhang","year":"2005","unstructured":"Zhang, J. et al. Uridine binding and transportability determinants of human concentrative nucleoside transporters. Mol. Pharmacol. 68, 830\u2013839 (2005).","journal-title":"Mol. Pharmacol."},{"key":"1559_CR41","doi-asserted-by":"publisher","first-page":"eabm7621","DOI":"10.1126\/scitranslmed.abm7621","volume":"14","author":"L Cao","year":"2022","unstructured":"Cao, L. et al. The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants. Sci. Transl. Med. 14, eabm7621 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1559_CR42","doi-asserted-by":"publisher","first-page":"eabm3410","DOI":"10.1126\/scitranslmed.abm3410","volume":"14","author":"A Schafer","year":"2022","unstructured":"Schafer, A. et al. Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice. Sci. Transl. Med. 14, eabm3410 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1559_CR43","unstructured":"NCT05603143: Study of obeldesivir in participants with COVID-19 who have a high risk of developing serious or severe illness (BIRCH). https:\/\/clinicaltrials.gov\/show\/NCT05603143 (2022)."},{"key":"1559_CR44","doi-asserted-by":"crossref","unstructured":"Qiu, B., Matthies, D., Fortea, E., Yu, Z. & Boudker, O. Cryo-EM structures of excitatory amino acid transporter 3 visualize coupled substrate, sodium, and proton binding and transport. Sci. Adv. 7, eabf5814 (2021).","DOI":"10.1126\/sciadv.abf5814"},{"key":"1559_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature12538","volume":"502","author":"GB Erkens","year":"2013","unstructured":"Erkens, G. B., H\u00e4nelt, I., Goudsmits, J. M., Slotboom, D. J. & van Oijen, A. M. Unsynchronised subunit motion in single trimeric sodium-coupled aspartate transporters. Nature 502, 119\u2013123 (2013).","journal-title":"Nature"},{"key":"1559_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nsmb.2494","volume":"20","author":"ER Georgieva","year":"2013","unstructured":"Georgieva, E. R., Borbat, P. P., Ginter, C., Freed, J. H. & Boudker, O. Conformational ensemble of the sodium-coupled aspartate transporter. Nat. Struct. Mol. Biol. 20, 215\u2013221 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1559_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14834-8","volume":"11","author":"V Arkhipova","year":"2020","unstructured":"Arkhipova, V., Guskov, A. & Slotboom, D. J. Structural ensemble of a glutamate transporter homologue in lipid nanodisc environment. Nat. Commun. 11, 998 (2020).","journal-title":"Nat. Commun."},{"key":"1559_CR48","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1042\/BST20200290","volume":"48","author":"AA Garaeva","year":"2020","unstructured":"Garaeva, A. A. & Slotboom, D. J. Elevator-type mechanisms of membrane transport. Biochem. Soc. Trans. 48, 1227\u20131241 (2020).","journal-title":"Biochem. Soc. Trans."},{"key":"1559_CR49","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1021\/acs.chemrev.0c00983","volume":"121","author":"D Drew","year":"2021","unstructured":"Drew, D., North, R. A., Nagarathinam, K. & Tanabe, M. Structures and general transport mechanisms by the major facilitator superfamily (MFS). Chem. Rev. 121, 5289\u20135335 (2021).","journal-title":"Chem. Rev."},{"key":"1559_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-020-1963-z","volume":"578","author":"AA Qureshi","year":"2020","unstructured":"Qureshi, A. A. et al. The molecular basis for sugar import in malaria parasites. Nature 578, 321\u2013325 (2020).","journal-title":"Nature"},{"key":"1559_CR51","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41586-022-05168-0","volume":"609","author":"NJ Wright","year":"2022","unstructured":"Wright, N. J. et al. Methotrexate recognition by the human reduced folate carrier SLC19A1. Nature 609, 1056\u20131062 (2022).","journal-title":"Nature"},{"key":"1559_CR52","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"1559_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"1559_CR54","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"1559_CR55","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1559_CR56","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: More and better reference data for improved all\u2010atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."},{"key":"1559_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"1559_CR58","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM\u2014GUI membrane builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997\u20132004 (2014).","journal-title":"J. Comput. Chem."},{"key":"1559_CR59","doi-asserted-by":"publisher","first-page":"e4446","DOI":"10.1002\/pro.4446","volume":"31","author":"D Suh","year":"2022","unstructured":"Suh, D. et al. CHARMM\u2014GUI enhanced sampler for various collective variables and enhanced sampling methods. Protein Sci. 31, e4446 (2022).","journal-title":"Protein Sci."},{"key":"1559_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"1559_CR61","doi-asserted-by":"publisher","first-page":"e880","DOI":"10.1371\/journal.pone.0000880","volume":"2","author":"S Jo","year":"2007","unstructured":"Jo, S., Kim, T. & Im, W. Automated builder and database of protein\/membrane complexes for molecular dynamics simulations. PLoS ONE 2, e880 (2007).","journal-title":"PLoS ONE"},{"key":"1559_CR62","doi-asserted-by":"publisher","first-page":"e1005659","DOI":"10.1371\/journal.pcbi.1005659","volume":"13","author":"P Eastman","year":"2017","unstructured":"Eastman, P. et al. OpenMM 7: rapid development of high performance algorithms for molecular dynamics. PLoS Comput. Biol. 13, e1005659 (2017).","journal-title":"PLoS Comput. Biol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01559-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T16:10:48Z","timestamp":1724861448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01559-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1559"],"URL":"https:\/\/doi.org\/10.1038\/s41589-024-01559-8","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}